Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Singular Genomics logo — Accelerating multiomics for the advancement of science and m...

Singular Genomics

Accelerating multiomics for the advancement of science and medicine.

Founded 2016 United States San Diego, United States 163 employees Acquired Total: $303.60M Biotechnology, Health Care

General Information

Company Name Singular Genomics
Founded Year 2016
Location United States San Diego, United States
Employees 163
Industries Biotechnology, Health Care
Funding Stage Acquired
Business Model B2B, Platform, SaaS
Revenue Model Product Sales, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Singular Genomics. To contact Singular Genomics, visit singulargenomics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Singular Genomics compare?

A PDF of Singular Genomics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Singular Genomics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Singular Genomics

Singular Genomics, founded in 2016, is a pioneering force in the Biotechnology and Health Care sectors. Headquartered in the United States, this innovative company is at the forefront of delivering the future of spatial pathology, guided by its slogan, "Accelerating multiomics for the advancement of science and medicine."

The company's flagship offering, the G4X Platform, is recognized as the first high throughput in situ multiomics technology. This revolutionary platform is strategically designed to facilitate breakthroughs in precision diagnostics and personalized medicine, offering substantial potential to redefine approaches within these fields.

The latest financial milestone for Singular Genomics is its acquisition investment on 01 December 2024, with the backing of significant investor Deerfield. Such an investment underscores growing confidence in the company's capability to lead in multiomics and spatial pathology domains.

Business keywords: multiomics, spatial pathology, precision diagnostics, personalized medicine, life science technology, next generation sequencing, Singular Sequencing Engine, NGS market, G4 Integrated Solution, PX Integrated Solution, single cell analysis, spatial analysis, genomics, proteomics

Services & Products

High Throughput Spatial Sequencing
Spatial and Multiomic Data Generation
Custom RNA and Protein Panels
3D Biological Insights
Sequencing Support

Target Customers

Pathology Departments Cancer Research Institutes Biotech and Pharma Companies Academic Medical Centers Clinical Researchers

Pricing

as listed on Sep 29, 2026

On request

Singular Genomics's pricing page

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Acquisition Undisclosed 1
Deerfield
01 Dec 2024
IPO $258.10M -
01 May 2021
Series B $45.50M 5
Coatue F-Prime Capital Domain Associates
Coatue, F-Prime Capital +3
01 Jan 2020
Round Undisclosed 1
F-Prime Capital
F-Prime Capital
01 Jan 2019
Spinout Undisclosed 1
Columbia University
01 Sep 2016
Seed Undisclosed 1
Domain Associates
Domain Associates
01 Jan 2016

Singular Genomics Alternatives & Competitors

View All Alternatives
Singular Genomics vs
Vizgen
Vizgen United States

Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...

Series E
153 employees
Biotechnology, Health Care
Compare Singular Genomics vs Vizgen
Singular Genomics vs
NanoString Technologies, Inc.
NanoString Technologies, Inc. United States

Mapping the universe of biology 🧬

IPO
225 employees
Biotechnology, Health Care
Compare Singular Genomics vs NanoString Technologies, Inc.
Singular Genomics vs
Nancy J Kelley + Associates
Nancy J Kelley + Associates United States

We build things that matter for science and medicine.

5 employees
Biotechnology, Financial Services
Also compare with: Singular Genomics vs IsoPlexis IsoPlexis View all alternatives

FAQ About Singular Genomics

Accelerating multiomics for the advancement of science and medicine.
Singular Genomics was founded in 2016.
Singular Genomics is headquartered in San Diego, United States.
Singular Genomics operates in Biotechnology and Health Care. Its work centres on multiomics, spatial pathology, precision diagnostics and personalized medicine. Its customers include Pathology Departments, Cancer Research Institutes and Biotech and Pharma Companies.
Singular Genomics has a B2B, Platform and SaaS business model. Its revenue comes from Product Sales, Usage Based and Service Fee.
As listed on Singular Genomics's pricing page on Sep 29, 2026: On request.
Singular Genomics has approximately 163 employees.
Singular Genomics has completed 6 funding rounds, raising a total of $303.60M. The latest funding stage is Acquired.
Singular Genomics offers: High Throughput Spatial Sequencing, Spatial and Multiomic Data Generation, Custom RNA and Protein Panels, 3D Biological Insights, Sequencing Support.
Top alternatives and competitors to Singular Genomics include Vizgen, NanoString Technologies, Inc., Nancy J Kelley + Associates, Mission Bio, Annoroad Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Singular Genomics and Vizgen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Singular Genomics, https://bouncewatch.com/company/singular-genomics, updated 26 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes